Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001322577 | SCV001513454 | likely benign | Noonan syndrome 9 | 2023-06-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377404 | SCV002623930 | uncertain significance | Cardiovascular phenotype | 2021-06-22 | criteria provided, single submitter | clinical testing | The p.H1301R variant (also known as c.3902A>G), located in coding exon 23 of the SOS2 gene, results from an A to G substitution at nucleotide position 3902. The histidine at codon 1301 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV001322577 | SCV002762967 | uncertain significance | Noonan syndrome 9 | criteria provided, single submitter | clinical testing |